Industry News
BIO’s long COVID webinar furthers search for biotech solutions
ORIGINAL SOURCE When it comes to long COVID, health care providers and the biotech industry must be aware of what is already known, but we still need to learn much more, participants at an online long COVID webinar co-organized by the Biotechnology Innovation Organization (BIO) were told yesterday. “While significant research efforts by the U.S.…
Read MorePhase IIB Bridge and Small Market Applications Due February 28th, 2023
The NHLBI Phase IIB Bridge (RFA-HL-23-009) and Small Market Award (RFA-HL-23-008) Programs can provide up to $3 Million over three (3) years to continue the commercialization of novel products in the NHLBI mission space, specifically towards the completion of milestones necessary to achieve regulatory approval. This work must represent an extension of work completed under an…
Read MoreVestaron Joins Leading Harvest as Program Supporter
Vestaron announces membership with Leading Harvest, an organization dedicated to improving the sustainability and efficiency of the agricultural industry. RTP, North Carolina, Feb 14, 2023 (GLOBE NEWSWIRE) — Vestaron, a leading producer of peptide-based bioinsecticides is proud to announce its membership as a Program Supporter of Leading Harvest, an industry leader in sustainability, created by and…
Read MoreMichigan Life Sciences Establishments Grow at Rate Higher Than the National Average, Says New Report
Tenth Biennial TEConomy/BIO Report Released ANN ARBOR, MI, UNITED STATES, November 8, 2022 /EINPresswire.com/ — The Biotechnology Innovation Organization (BIO) released its tenth biennial report “The U.S. Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward” with new employment and economic impact data (through 2021) for the nation’s biosciences industry The report, produced in partnership with TEConomy,…
Read MoreThermo Fisher Scientific weighs in on the need for more disruptive technologies to advance healthcare in India during the Conference on Application of New-age technologies in Diagnostics
7th Oct 2022, New Delhi: Thermo Fisher Scientific, the world leader in serving science, recently participated in a conference on the Application of New-age Technologies in Diagnostics organized by the Confederation of Indian Industry (CII) Northern Regional Committee on Diagnostics and Technology. CII is a non-government, not-for-profit, industry-led organization, that is engaged in creating…
Read MoreHospitals and pharmacies profit as 340B drives up patients’ drug costs
Original Source The federal 340B Drug Pricing Program is starting to get a great deal of attention—for all the wrong reasons. The program was started in 1992 with the goal of allowing hospitals and clinics that work with underserved communities to provide outpatient prescription drugs to patients at deep discounts. Now, after 30 years,…
Read MoreBiomanufacturing to get a boost from Biden’s new executive order
US President Joe Biden signed an executive order on Monday that will “help expand U.S. biomanufacturing and reduce reliance on China,” according to Bloomberg. The executive order will launch a National Biotechnology and Biomanufacturing Initiative that will accelerate biotechnology innovation and grow America’s bioeconomy across multiple sectors, including a range of industries, including health, agriculture, and energy, the White…
Read MoreEfforts at value-based care focus on patients’ needs
Original Source What is the value of a treatment? As of July, the U.S. government has given out close to 600 million doses of COVID-19 vaccines at prices that ranged between $15-$20 per dose, which means they spent $10-$12 billion on shots. Research shows that, as of March, the U.S. vaccination program saved 2 million lives and $900 billion in…
Read MorePrice Controls Would Devastate Drug Development, Patient Access, Says New Analysis
Original Source: https://vitaltransformation.com/2022/07/build-back-better-act-total-market-impact-of-price-controls-in-medicare-parts-d-and-b/ Build Back Better Act Total market impact of price controls in Medicare parts D and B The Executive Summary The Build Back Better Act (BBBA) is designed to allow the US Government to ‘negotiate’ pricing under a set framework of reductions based upon the amount of time a drug has spent on…
Read MoreNew Funding Opportunity from the NIH: Small Business Transition Grant For Early Career Scientists
The National Cancer Institute (NCI) recently released a new funding opportunity for biotech companies and university researchers! The new Small Business Transition Grant funds the translation of technology from university to small business, as well as the transition of early career researchers from academia to industry. This award uses the Small Business Technology Transfer (STTR)…
Read More